Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2587-2592

  Panagopoulos, Ioannis ^a,b   Gorunova, Ludmila ^a,b   Zeller, Bernward ^c   Tierens, Anne ^a   Heim, Sverre ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myeloid leukemia; ERG; FUS; Fusion gene; RNA sequencing

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; AMINO ACID; CD123 ANTIGEN; CD133 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYTARABINE; ETOPOSIDE; FLUDARABINE; FUS ERG FUSION PROTEIN; HEMOGLOBIN; HYBRID PROTEIN; IDARUBICIN; LACTATE DEHYDROGENASE; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; MYELOPEROXIDASE; PENICILLIN DERIVATIVE; STEM CELL FACTOR RECEPTOR; TIOGUANINE; TRANSCRIPTOME; TRIACYLGLYCEROL LIPASE; TUMOR MARKER; UNCLASSIFIED DRUG; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; BONE MARROW EXAMINATION; CASE REPORT; CHILD; CHIMERA; CHOLESTASIS; CHROMOSOME 16P; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CYTOGENETICS; DETERIORATION; DRUG MEGADOSE; EXON; FEMALE; FEVER; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FUS ERG FUSION GENE; FUSION GENE; G BANDING ANALYSIS; GENETIC TRANSCRIPTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; KARYOTYPE; LEUKOCYTE COUNT; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PANCREATITIS; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; REMISSION; RNA SEQUENCE; SEQUENCE ANALYSIS; SORE THROAT; THROMBOCYTE COUNT;

CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; RNA-BINDING PROTEIN FUS;

EID: 84892384217     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2751     Document Type: Article

References (32)

1. Ichikawa H, Shimizu K, Hayashi Y and Ohki M: An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54: 2865-2868, 1994.
2. Panagopoulos I, Aman P, Fioretos T, et al: Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosomes Cancer 11: 256-262, 1994.
3. Fukushima Y, Fujii N, Tabata Y, et al: [AML(M7) associated with t(16;21)(p11;q22) showing relapse after unrelated bone marrow transplantation and disappearance of TLS/FUS-ERG mRNA]. Rinsho Ketsueki 42: 502-506, 2001.
4. Kong XT, Ida K, Ichikawa H, et al: Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 90: 1192-1199, 1997.
5. Kanazawa T, Ogawa C, Taketani T, Taki T, Hayashi Y and Morikawa A: TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leuk Lymphoma 46: 1833-1835, 2005.
6. Manola KN, Georgakakos VN, Stavropoulou C, et al: Jumping translocations in hematological malignancies: a cytogenetic study of five cases. Cancer Genet Cytogenet 187: 85-94, 2008.
7. Pereira DS, Dorrell C, Ito CY, et al : Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci USA 95: 8239-8244, 1998.
8. Berg T, Kalsaas AH, Buechner J and Busund LT: Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript. Cancer Genet Cytogenet 194: 53-57, 2009.
9. Shing DC, McMullan DJ, Roberts P, et al: FUS/ERG gene fusions in Ewing's tumors. Cancer Res 63: 4568-4576, 2003.
10. Zou J, Ichikawa H, Blackburn ML, et al: The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts. Mol Cell Biol 25: 6235-6246, 2005.
11. Shimizu K, Ichikawa H, Tojo A, et al: An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromoomal translocation. Proc Natl Acad Sci USA 90: 10280-10284, 1993.
12. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6: 146-151, 1994.
13. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12: 4481-4487, 1993.
14. Crozat A, Aman P, Mandahl N and Ron D: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363: 640-644, 1993.
15. Rabbitts TH, Forster A, Larson R and Nathan P: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4: 175-180, 1993.
16. Maher CA, Kumar-Sinha C, Cao X, et al: Transcriptome sequencing to detect gene fusions in cancer. Nature 458: 97-101, 2009.
17. Tanas MR, Sboner A, Oliveira AM, et al: Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3: 98ra82, 2011.
18. Lee CH, Ou WB, Marino-Enriquez A, et al: 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci USA 109: 929-934, 2012.
19. Panagopoulos I, Thorsen J, Gorunova L, et al: Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer 52: 610-618, 2013.
20. Nyquist KB, Panagopoulos I, Thorsen J, et al: Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma. PLoS One 7: e49705, 2012.
21. Panagopoulos I, Thorsen J, Gorunova L, et al: RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12). Genes Chromosomes Cancer 52: 733-740, 2013.
22. Micci F, Thorsen J, Haugom L, Zeller B, Tierens A and Heim S: Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia. Leukemia 25: 1510-1512, 2011.
23. Micci F, Thorsen J, Panagopoulos I, et al : High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24). Leukemia 27: 980-982, 2013.
24. Panagopoulos I, Micci F, Thorsen J, et al: Fusion of ZMYND8 and RELA genes in acute erythroid leukemia. PLoS One 8: e63663, 2013.
25. Abrahamsson J, Forestier E, Heldrup J, et al : Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. J Clin Oncol 29: 310-315, 2011.
26. Schaffer LG, Slovak ML and Campbell LJ: ISCN 2009: an International System for Human Cytogenetic Nomenclature. Karger, Basel, 2009.
27. Ge H, Liu K, Juan T, Fang F, Newman M and Hoeck W: FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 27: 1922-1928, 2011.
28. Duhoux FP, Ameye G, Montano-Almendras CP, et al: PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies. Br J Haematol 156: 76-88, 2012.
29. Gamou T, Kitamura E, Hosoda F, et al : The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91: 4028-4037, 1998.
30. Gruber TA, Larson Gedman A, Zhang J, et al : An Inv(16)(p13.3q24.3)- encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22: 683-697, 2012.
31. Oh SH, Park TS, Choi JR, et al: Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript. Cancer Genet Cytogenet 200: 180-183, 2010.
32. Ichikawa H, Shimizu K, Katsu R and Ohki M: Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol Cell Biol 19: 7639-7650, 1999.